Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT, with subsequent surgical correlation

Radiology

Volumn 210, Issue 3, 1999, Pages 625-632

  Low, Russell N ^a   Semelka, Richard C ^b   Worawattanakul, Suvipapun ^b   Alzate, Gregg D ^a   Sigeti, Joel S ^a  

^a SHARP MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Abdomen, neoplasms; Magnetic resonance (MR), comparative studies; Neoplasms, CT; Neoplasms, MR

Indexed keywords

BARIUM SULFATE; CONTRAST MEDIUM; DIATRIZOATE; GADOLINIUM CHELATE; GADOLINIUM PENTETATE; GADOVERSETAMIDE; IOHEXOL; READICAT; UNCLASSIFIED DRUG;

ABDOMINAL TUMOR; ADULT; AGED; ARTICLE; BILIARY TRACT CANCER; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PANCREAS CANCER; PERITONEUM CANCER; PRIORITY JOURNAL; UROGENITAL TRACT CANCER;

EID: 0032976594     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.210.3.r99mr46625     Document Type: Article

References (38)

1. Chezmar JL, Rumancik WM, Megibow AJ, Hulnick DH, Nelson RC, Bernadino ME. Liver and abdominal screening in patients with cancer: CT versus MR imaging. Radiology 1988; 168:43-47.
2. Heiken JP, Weyman PJ, Lee JKT, et al. Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 1989; 171:47-51.
3. Nelson RC, Chezmar JL, Sugarbaker PH, Bernardino ME. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology 1989; 172:27-34.
4. Megibow AJ, Zhou XH, Rotterdam H, et al. Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability -report of the Radiology Diagnostic Oncology Group. Radiology 1995; 195:327-332.
5. Muller MF, Meyenberger C, Bertschinger P, Schaer R, Marincek B. Pancreatic tumors: evaluation with endoscopic US, CT, and MR imaging. Radiology 1994; 190:745-751.
6. Cohan RH, Sherman LS, Korobkin M, Bass JC, Francis IR. Renal masses: assessment of corticomedullary-phase and nephrographic-phase CT scans. Radiology 1995; 196:445-451.
7. Jamis-Dow CA, Choyke PL, Jennings SB, Marston Linehan W, Thakore KN, Walther MM. Small (≤3 cm) renal masses: detection with CT versus US and pathologic correlation. Radiology 1996; 198:785-788.
8. Korobkin M, Brodeur FJ, Yutzy GG, et al. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR 1966; 166:531-536.
9. Zerhouni EA, Rutter C, Hamilton SR, et al. CT and MR imaging in the staging of colorectal carcinoma: report of the Radiology Diagnostic Oncology Group II. Radiology 1996; 200: 443-451.
10. Larson RE, Semelka RC, Bagley AS, Molina PL, Brown ED, Lee JKT. Hypervascular malignant liver lesions: comparison of various MR imaging pulse sequences and dynamic CT. Radiology 1994; 192:393-399.
11. Hamm B, Thoeni RF, Gould RG, et al. Focal liver lesions: characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology 1994; 190: 417-423.
12. Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. JMRI 1997; 7:1040-1047.
13. Yamashita Y, Mitsuzaki K, Yi T, et al. Small hepatocellular carcinoma in patients with chronic liver damage: prospective comparison of detection with dynamic MR imaging and helical CT of the whole liver. Radiology 1996; 200:79-84.
14. Semelka RC, Schlund JF, Molina RL, et al. Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. JMRI 1996; 6:39-43.
15. Semelka RC, Willms AB, Brown MA, Brown ED, Finn JP. Comparison of breath-hold T1-weighted MR sequences for imaging of the liver. JMRI 1994; 4:759-765.
16. Low RN, Francis IR, Sigeti JS, Foo TKF. Abdominal MR imaging: comparison of T2-weighted fast and conventional spin-echo and contrast-enhanced fast multiplanar spoiled gradient-recalled imaging. Radiology 1993; 186:803-811.
17. Outwater EK, Mitchell DG, Vinitski S. Abdominal MR imaging: evaluation of a fast spin-echo sequence. Radiology 1994; 190:425-429.
18. Rydberg JN, Lomas DJ, Coakley KJ, et al. Comparison of breath-hold fast spin-echo and conventional spin-echo pulse sequences for T2-weighted MR imaging of liver lesions. Radiology 1995; 194:431-437.
19. Low RN. Contrast agents for MR imaging of the liver. JMRI 1997; 7:56-67.
20. Low RN, Barone RM, Lacey C, Sigeti JS, Alzate GD, Sebrechts CP. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. Radiology 1997; 204:513-520.
21. Low RN, Carter WD, Saleh F, Sigeti JS. Ovarian cancer: comparison of findings with perfluorocarbon-enhanced MR imaging, In-111-CYT-103 immunoscintigraphy, and CT. Radiology 1995; 195:391-400.
22. Low RN, Francis IR. MR imaging of the gastrointestinal tract with IV gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT. AJR 1997; 169:1051-1059.
23. Matsushita M, Oi H, Murakami T, et al. Extraserosal invasion in advanced gastric cancer: evaluation with MR imaging. Radiology 1994; 192:87-91.
24. Rofsky NM, Weinreb JC, Bosniak MA, Libes RB, Birnbaum BA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991; 180:85-89.
25. Semelka RC, Cumming MJ, Shoenut JP, et al. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 1993; 186:799-802.
26. Semelka RC, Kroeker MA, Shoenut JP, Kroeker R, Yaffe CS, Micflikier AB. Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression. Radiology 1991; 181:785-791.
27. Zeman RK, Fox SH, Silverman PM, et al. Helical (spiral) CT of the abdomen. AJR 1993; 160:719-725.
28. Hollett MD, Jeffrey RB, Nino-Murcia M, Jorgensen MJ, Harris DP. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (<1.5 cm) malignant hepatic neoplasms. AJR 1995; 164:879-884.
29. Bluemke DA, Cameron JL, Hruban RH, et al. Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 1995; 197: 381-385.
30. Low RN, Sigeti JS, Francis IR, et al. Evaluation of malignant biliary obstruction: efficacy of fast multiplanar spoiled gradient-recalled MR imaging vs spin-echo MR, CT, and cholangiography. AJR 1994; 162:315-323.
31. Semelka RC, Shoenut JP, Kroeker MA, et al. Bile duct disease: prospective comparison of ERCP, CT and fat-suppressed MRI. Gastrointest Radiol 1992; 17:347-352.
32. Semelka RC, Shoenut JP, Magro CM, Kroeker MA, MacMahon R, Greenberg HM. Renal cancer staging: comparison of contrast-enhanced CT and gadolinium-enhanced fat-suppressed spin-echo and gradient-echo MR imaging. JMRI 1993; 3:597-602.
33. Ichikawa T, Hardome H, Hachiya J, et al. Pancreatic ductal adenocarcinoma: preoperative assessment with helical CT versus dynamic MR imaging. Radiology 1997; 202:655-662.
34. Semelka RC, Kelekis NL, Molina PL, Sharp TJ, Calvo B. Pancreatic masses with inconclusive findings on spiral CT: is there a role for MRI? JMRI 1996; 6:585-588.
35. Semelka RC, Shoenut JP, Silverman R, Kroeker MA, Yaffe CS, Micflikier AB. Bowel disease: prospective comparison of CT and 1.5-T pre- and postcontrast MR imaging with Tl-weighted fat-suppressed and breath-hold FLASH sequences. JMRI 1991; 1:625-632.
36. Mayo-Smith WW, Lee MJ, McNicholas MMJ, Hahn PF, Boland GW, Saini S. Characterization of adrenal masses (<5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR 1995; 165:91-95.
37. Mitchell DG, Crovello M, Matteucci T, et al. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992; 185:345-351.
38. Outwater EK, Siegelman ES, Tadecki PD, Piccoli CW, Mitchell DG. Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. AJR 1995; 165:579-583.